Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia

This study has been completed.
Information provided by (Responsible Party):
ViroMed Co., Ltd. dba VM BioPharma Identifier:
First received: February 4, 2010
Last updated: October 14, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 16, 2015